Regulation of the CB1R/AMPK/PGC-1α signaling pathway in mitochondria of mouse hearts and cardiomyocytes with chronic intermittent hypoxia-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Regulation of the CB1R/AMPK/PGC-1α signaling pathway in mitochondria of mouse hearts and cardiomyocytes with chronic intermittent hypoxia

Published:2023-07-10 Issue: Volume: Page:
ISSN:1520-9512
Container-title:Sleep and Breathing
language:en
Short-container-title:Sleep Breath

Author:

Hu Zixuan,Mu Sufang,Zhao Li,Dou Zhanjun,Wang Peipei,Zhang Junfeng,Jin Ning,Lu Xin,Xu Xinrui,Liang Ting,Duan Yuting,Xiong Yang,Wang Bei

Funder

Shanxi Provincial Key Research and Development Project

The scientific research project of the Shanxi Health and Family Planning Commission

Publisher

Springer Science and Business Media LLC

Subject

Neurology (clinical),Otorhinolaryngology

Link

https://link.springer.com/content/pdf/10.1007/s11325-023-02863-8.pdf

Reference38 articles.

1. Strausz S, Ruotsalainen S, Ollila HM et al (2021) Genetic analysis of obstructive sleep apnoea discovers a strong association with cardiometabolic health. Eur Respir J 57:2003091. https://doi.org/10.1007/10.1183/13993003.03091-2020

2. Gottlieb DJ, Punjabi NM (2020) Diagnosis and management of obstructive sleep apnea: a review. JAMA 323:1389–1400. https://doi.org/10.1007/10.1001/jama.2020.3514

3. Benjafield AV, Ayas NT, Eastwood PR et al (2019) Estimation of the global prevalence and burden of obstructive sleep apnoea: a literature-based analysis. Lancet Respir Med 7:687–698. https://doi.org/10.1007/10.1016/S2213-2600(19)30198-5

4. Bock JM, Vungarala S, Karim S et al (2021) Obstructive sleep apnea as a cardiovascular risk factor—beyond CPAP. Can J Cardiol 37:756–765. https://doi.org/10.1007/10.1016/j.cjca.2021.01.027

5. Lebkuchen A, Freitas LS, Cardozo KHM et al (2021) Advances and challenges in pursuing biomarkers for obstructive sleep apnea: implications for the cardiovascular risk. Trends Cardiovasc Med 31:242–249. https://doi.org/10.1007/10.1016/j.tcm.2020.04.003

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Re-evaluation of the cardioprotective effects of cannabinoids against ischemia-reperfusion injury according to the IMproving Preclinical Assessment of Cardioprotective Therapies (IMPACT) criteria;Frontiers in Pharmacology;2024-05-30

2. Chronic intermittent hypoxia aggravated diabetic cardiomyopathy through LKB1/AMPK/Nrf2 signaling pathway;PLOS ONE;2024-03-07

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3